DEMSKI MARTHA J 4
4 · Equillium, Inc. · Filed May 29, 2026
Research Summary
AI-generated summary of this filing
Equillium (EQ) Director Martha J Demski Receives Award
What Happened
Martha J. Demski, a director of Equillium, Inc. (EQ), was granted a 70,000-share derivative award on May 28, 2026. The award is reported at $0.00 per share (no cash paid on grant in the filing). The grant is not an immediate sale or market purchase — it is a vested-equity award subject to a vesting schedule.
Key Details
- Transaction type: Grant / award (derivative) of 70,000 shares reported as $0.00 per share.
- Transaction date: 2026-05-28; Form 4 filed 2026-05-29 (reporting appears timely).
- Vesting: Vests in 12 equal monthly installments beginning May 28, 2026; will be fully vested on the date of the issuer’s next annual meeting of stockholders (per footnote).
- Shares owned after transaction: Not specified in the provided filing excerpt—see the full Form 4 for total holdings.
- No 10b5-1 plan, tax-withholding, cashless exercise, or late-filing flags noted in the provided details.
Context
This is a grants/award filing (code A) for a derivative equity instrument. Such awards typically represent future upside exposure if the shares become vested or if an option is exercised; they do not represent an immediate market purchase or sale. For full ownership impact and any subsequent exercises or sales, monitor future Form 4 filings from the insider.
Insider Transaction Report
- Award
Director Stock Option (right to buy)
[F1]2026-05-28+70,000→ 70,000 totalExercise: $2.84Exp: 2036-05-27→ Common Stock (70,000 underlying)
Footnotes (1)
- [F1]The option vests in twelve equal monthly installments commencing on the grant date of May 28, 2026, provided that the option will, in any case, be fully vested on the date of the Issuer's annual meeting of stockholders following the grant date.